$590 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 128 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 69.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVS | Sell | Novartis AGsponsored adr | $40,846,000 | -9.6% | 439,621 | -8.2% | 6.96% | +24.7% |
| B108PS | Sell | Actavis plc | $27,569,000 | -6.4% | 107,100 | -12.3% | 4.70% | +29.1% |
| PFE | Sell | Pfizer Inc | $27,226,000 | -27.7% | 874,013 | -31.4% | 4.64% | -0.3% |
| TEVA | Sell | Teva Pharmaceutical Industriesadr | $22,790,000 | -34.6% | 396,269 | -38.8% | 3.88% | -9.8% |
| SLXP | Buy | SALIX PHARMACEUTICALS LT | $18,218,000 | +483.0% | 158,500 | +692.5% | 3.10% | +704.1% |
| GILD | New | Gilead Sciences Inc | $17,909,000 | – | 190,000 | +100.0% | 3.05% | – |
| SHPG | Sell | Shire PLCsponsored adr | $15,886,000 | -29.2% | 224,751 | -13.3% | 2.71% | -2.3% |
| VRX | Valeant Pharmaceuticals Intern | $14,103,000 | +9.1% | 98,550 | 0.0% | 2.40% | +50.5% | |
| BIIB | New | Biogen Idec Inc | $13,578,000 | – | 40,000 | +100.0% | 2.31% | – |
| ISRL | Sell | Isramco Negev 2 LP | $11,134,000 | -49.7% | 64,958,387 | -37.0% | 1.90% | -30.6% |
| UTHR | Sell | United Therapeutics Corp | $9,562,000 | -16.3% | 73,840 | -16.9% | 1.63% | +15.4% |
| New | Merck & Co Inc | $9,514,000 | – | 167,530 | +100.0% | 1.62% | – | |
| MNKKQ | Sell | Mallinckrodt PLC | $9,006,000 | -26.5% | 90,940 | -33.1% | 1.53% | +1.3% |
| BMY | New | Bristol-Myers Squibb Co | $8,855,000 | – | 150,000 | +100.0% | 1.51% | – |
| ESLT | Elbit Systems Ltdord | $8,853,000 | -1.3% | 144,759 | 0.0% | 1.51% | +36.0% | |
| VRNT | Sell | Verint Systems Inc | $8,515,000 | +1.1% | 146,108 | -3.5% | 1.45% | +39.4% |
| New | Allergan Inc/United Statescall | $8,238,000 | – | 250,000 | +100.0% | 1.40% | – | |
| BMRN | Sell | BioMarin Pharmaceutical Inc | $7,232,000 | -17.8% | 80,000 | -34.4% | 1.23% | +13.3% |
| New | Bellicum Pharmaceuticals | $6,956,000 | – | 331,514 | +100.0% | 1.18% | – | |
| IWM | New | iShares Russell 2000 Index Funrussell 2000 etf | $6,495,000 | – | 54,300 | +100.0% | 1.11% | – |
| KITE | Buy | Kite Pharma Inc | $6,400,000 | +230.4% | 110,970 | +63.3% | 1.09% | +356.1% |
| GCVRZ | Sanofiright 12/31/2020 | $6,222,000 | -19.1% | 67,960 | 0.0% | 1.06% | +11.6% | |
| Sell | AstraZeneca PLCsponsored adr | $6,098,000 | -28.9% | 86,637 | -27.8% | 1.04% | -1.9% | |
| LLY | Sell | Eli Lilly & Co | $6,009,000 | -4.6% | 87,100 | -10.3% | 1.02% | +31.6% |
| PCYC | Buy | Pharmacyclics Inc | $5,971,000 | +30.9% | 48,840 | +25.7% | 1.02% | +80.6% |
| Buy | Apple Inc | $5,828,000 | +15.6% | 52,803 | +5.5% | 0.99% | +59.4% | |
| ASPX | Sell | Auspex Pharmaceuticals Inc | $5,777,000 | +36.3% | 110,074 | -33.3% | 0.98% | +88.1% |
| PTCT | Buy | PTC Therapeutics Inc | $5,695,000 | +103.4% | 110,000 | +72.9% | 0.97% | +180.3% |
| MYL | Mylan Inc/PA | $5,474,000 | +23.9% | 97,100 | 0.0% | 0.93% | +70.9% | |
| New | Amgen Inccall | $5,457,000 | – | 120,200 | +100.0% | 0.93% | – | |
| AMAG | Sell | AMAG Pharmaceuticals Inc | $5,337,000 | +11.3% | 125,230 | -16.6% | 0.91% | +53.5% |
| MDVN | Sell | Medivation Inc | $5,291,000 | -15.2% | 53,115 | -15.8% | 0.90% | +16.9% |
| VNDA | Buy | Vanda Pharmaceuticals Inc | $5,275,000 | +132.7% | 368,390 | +68.7% | 0.90% | +221.1% |
| XLF | New | Financial Select Sector SPDR Fsbi int-finl | $5,193,000 | – | 210,000 | +100.0% | 0.88% | – |
| TW | Buy | Towers Watson & Cocl a | $4,793,000 | +72.0% | 42,350 | +51.2% | 0.82% | +137.5% |
| TJX | Buy | TJX Cos Inc | $4,638,000 | +184.0% | 67,630 | +145.0% | 0.79% | +291.1% |
| ARRY | Buy | Array BioPharma Inc | $4,607,000 | +47.7% | 973,922 | +11.4% | 0.78% | +103.9% |
| CLVS | Sell | Clovis Oncology Inc | $4,589,000 | -0.8% | 81,955 | -19.6% | 0.78% | +37.0% |
| FOLD | New | Amicus Therapeutics Inc | $4,576,000 | – | 550,000 | +100.0% | 0.78% | – |
| DYAX | Sell | Dyax Corp | $4,465,000 | -14.8% | 317,556 | -38.6% | 0.76% | +17.6% |
| GSK | Buy | GlaxoSmithKline PLCsponsored adr | $4,197,000 | -6.0% | 98,200 | +1.1% | 0.72% | +29.8% |
| FWP | New | Forward Pharma A/Ssponsored adr | $4,166,000 | – | 200,000 | +100.0% | 0.71% | – |
| ORBK | Sell | Orbotech Ltdord | $4,157,000 | -53.3% | 280,872 | -50.9% | 0.71% | -35.6% |
| Buy | Gilead Sciences Inccall | $3,954,000 | -80.9% | 394,200 | +103.0% | 0.67% | -73.6% | |
| CYTK | Buy | Cytokinetics Inc | $3,951,000 | +208.9% | 493,212 | +35.8% | 0.67% | +325.9% |
| RLYP | Buy | Relypsa Inc | $3,915,000 | +91.2% | 127,100 | +30.9% | 0.67% | +163.6% |
| BRCM | Sell | Broadcom Corpcl a | $3,848,000 | -4.2% | 88,800 | -10.6% | 0.66% | +32.3% |
| PBYI | Sell | Puma Biotechnology Inc | $3,841,000 | -46.9% | 20,296 | -33.0% | 0.65% | -26.8% |
| CBAY | Sell | Cymabay Therapeutics Inc | $3,837,000 | +14.4% | 390,355 | -20.4% | 0.65% | +58.0% |
| ITRN | Sell | Ituran Location and Control Lt | $3,714,000 | -23.6% | 168,203 | -27.2% | 0.63% | +5.3% |
| RCPT | Buy | Receptos Inc | $3,675,000 | +136.6% | 30,000 | +20.0% | 0.63% | +226.0% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $3,564,000 | -78.8% | 30,000 | -80.0% | 0.61% | -70.8% |
| CVS | Sell | CVS Caremark Corp | $3,526,000 | +11.3% | 36,610 | -8.0% | 0.60% | +53.7% |
| AGTC | Sell | Applied Genetic Technologies C | $3,471,000 | -11.5% | 165,124 | -21.6% | 0.59% | +21.9% |
| AEGR | New | Aegerion Pharmaceuticals Inc | $3,350,000 | – | 160,000 | +100.0% | 0.57% | – |
| XLV | Health Care Select Sector SPDRsbi healthcare | $3,341,000 | +7.0% | 48,853 | 0.0% | 0.57% | +47.4% | |
| TRVN | Buy | Trevena Inc | $3,288,000 | +54.7% | 549,811 | +66.1% | 0.56% | +112.9% |
| ACOR | Sell | Acorda Therapeutics Inc | $3,233,000 | -52.1% | 79,105 | -60.3% | 0.55% | -33.9% |
| CPRX | Buy | Catalyst Pharmaceutical Partne | $3,148,000 | +38.3% | 1,060,000 | +54.6% | 0.54% | +90.7% |
| MRNS | Marinus Pharmaceuticals Inc | $3,094,000 | +62.9% | 293,533 | 0.0% | 0.53% | +124.3% | |
| UNP | Sell | Union Pacific Corp | $3,060,000 | -12.6% | 25,689 | -20.5% | 0.52% | +20.3% |
| SGMO | New | Sangamo Biosciences Inc | $3,042,000 | – | 200,000 | +100.0% | 0.52% | – |
| MGNX | Sell | MacroGenics Inc | $2,953,000 | +31.1% | 84,198 | -21.9% | 0.50% | +80.9% |
| New | Arrowhead Research Corp | $2,952,000 | – | 400,000 | +100.0% | 0.50% | – | |
| CLDN | Sell | Celladon Corp | $2,942,000 | +51.5% | 150,656 | -18.9% | 0.50% | +108.8% |
| SAGE | Sell | SAGE Therapeutics Inc | $2,918,000 | +5.3% | 79,724 | -9.3% | 0.50% | +45.3% |
| Sell | Alder Biopharmaceuticals Inc | $2,909,000 | +52.9% | 100,000 | -33.3% | 0.50% | +111.1% | |
| DRNA | New | Dicerna Pharmaceuticals Inc | $2,912,000 | – | 176,802 | +100.0% | 0.50% | – |
| SNA | Buy | Snap-on Inc | $2,891,000 | +48.3% | 21,140 | +31.3% | 0.49% | +104.6% |
| ESRX | New | Express Scripts Holding Co | $2,876,000 | – | 33,966 | +100.0% | 0.49% | – |
| P103PS | Sell | NPS Pharmaceuticals Inc | $2,862,000 | -21.0% | 80,000 | -42.6% | 0.49% | +8.9% |
| KERX | New | Keryx Biopharmaceuticals Inc | $2,830,000 | – | 200,000 | +100.0% | 0.48% | – |
| PRQR | Sell | ProQR Therapeutics BV | $2,817,000 | -18.1% | 130,000 | -35.0% | 0.48% | +12.9% |
| MDCO | New | Medicines Co/The | $2,767,000 | – | 100,000 | +100.0% | 0.47% | – |
| OCRX | Buy | Ocera Therapeutics Inc | $2,683,000 | +70.5% | 421,254 | +31.1% | 0.46% | +135.6% |
| TKMR | New | Tekmira Pharmaceuticals Corp | $2,651,000 | – | 175,000 | +100.0% | 0.45% | – |
| AERI | Sell | Aerie Pharmaceuticals Inc | $2,584,000 | -23.6% | 88,516 | -45.9% | 0.44% | +5.3% |
| SRPT | New | Sarepta Therapeutics Inc | $2,532,000 | – | 175,000 | +100.0% | 0.43% | – |
| QURE | New | uniQure B.V. | $2,494,000 | – | 168,415 | +100.0% | 0.42% | – |
| BCOMF | Sell | B Communications Ltd | $2,418,000 | -60.8% | 134,174 | -58.3% | 0.41% | -46.0% |
| CEMP | New | Cempra Inc | $2,351,000 | – | 100,000 | +100.0% | 0.40% | – |
| TKAI | Sell | Tokai Pharmaceuticals Inc | $2,268,000 | -34.9% | 153,841 | -33.1% | 0.39% | -10.2% |
| ZFGN | Sell | Zafgen Inc | $2,224,000 | +16.6% | 72,100 | -25.7% | 0.38% | +60.6% |
| CSX | Sell | CSX Corp | $2,161,000 | -51.7% | 59,648 | -57.3% | 0.37% | -33.5% |
| ORA | Buy | Ormat Industries | $2,132,000 | +308.4% | 309,000 | +1453.6% | 0.36% | +467.2% |
| VTL | New | Vital Therapies Inc | $2,042,000 | – | 81,900 | +100.0% | 0.35% | – |
| ENTA | New | Enanta Pharmaceuticals Inc | $2,034,000 | – | 40,000 | +100.0% | 0.35% | – |
| NICE | Sell | NICE Systems Ltdsponsored adr | $2,008,000 | -23.4% | 39,652 | -38.6% | 0.34% | +5.6% |
| CNCE | Buy | Concert Pharmaceuticals Inc | $1,998,000 | +598.6% | 150,000 | +560.8% | 0.34% | +871.4% |
| PTLA | New | Portola Pharmaceuticals Inc | $1,982,000 | – | 70,000 | +100.0% | 0.34% | – |
| ELLO | Buy | Ellomay Capital Ltd | $1,977,000 | +4.5% | 203,778 | +6.6% | 0.34% | +44.0% |
| SBUX | New | Starbucks Corp | $1,969,000 | – | 24,000 | +100.0% | 0.34% | – |
| LJPC | Sell | La Jolla Pharmaceutical Co | $1,849,000 | -13.8% | 100,230 | -55.1% | 0.32% | +18.9% |
| Buy | Teva Pharmaceutical Industriescall | $1,801,000 | -91.1% | 464,200 | +23.7% | 0.31% | -87.7% | |
| CTIC | New | Cell Therapeutics Inc | $1,770,000 | – | 750,000 | +100.0% | 0.30% | – |
| ICPT | Sell | Intercept Pharmaceuticals Inc | $1,560,000 | -54.7% | 10,000 | -31.3% | 0.27% | -37.6% |
| CKP | New | Check Point Software Technolog | $1,547,000 | – | 19,688 | +100.0% | 0.26% | – |
| ACHN | New | Achillion Pharmaceuticals Inc | $1,538,000 | – | 125,538 | +100.0% | 0.26% | – |
| Valeant Pharmaceuticals Interncall | $1,395,000 | -89.1% | 97,200 | 0.0% | 0.24% | -84.9% | ||
| Sell | Amgen Inc | $1,362,000 | -80.0% | 8,550 | -82.4% | 0.23% | -72.4% | |
| PRTA | Buy | Prothena Corp PLC | $1,300,000 | +96.1% | 62,632 | +109.4% | 0.22% | +169.5% |
| WIX | New | Wix.com Ltd | $1,241,000 | – | 59,108 | +100.0% | 0.21% | – |
| RXDX | Sell | Ignyta Inc | $1,227,000 | -23.5% | 179,055 | -10.0% | 0.21% | +5.6% |
| GNVC | GenVec Inc | $1,195,000 | +2.9% | 558,325 | 0.0% | 0.20% | +42.7% | |
| MannKind Corpput | $1,155,000 | -34.9% | 300,000 | 0.0% | 0.20% | -10.0% | ||
| MDGN | New | Medgenics Inc | $1,139,000 | – | 225,000 | +100.0% | 0.19% | – |
| NBIX | New | Neurocrine Biosciences Inc | $1,117,000 | – | 50,000 | +100.0% | 0.19% | – |
| KMDA | New | Kamada Ltd | $1,089,000 | – | 293,727 | +100.0% | 0.19% | – |
| EBIO | New | Eleven Biotherapeutics Inc | $1,035,000 | – | 87,110 | +100.0% | 0.18% | – |
| RPRX | New | Repros Therapeutics Inc | $997,000 | – | 100,000 | +100.0% | 0.17% | – |
| NLNK | New | NewLink Genetics Corp | $994,000 | – | 25,000 | +100.0% | 0.17% | – |
| ZSPH | ZS Pharma Inc | $860,000 | +6.0% | 20,682 | 0.0% | 0.15% | +47.0% | |
| ONTY | Oncothyreon Inc | $813,000 | -1.1% | 428,000 | 0.0% | 0.14% | +36.3% | |
| JUNO | New | Juno Therapeutics Inc | $783,000 | – | 15,000 | +100.0% | 0.13% | – |
| MSTX | New | Mast Therapeutics Inc | $770,000 | – | 1,374,900 | +100.0% | 0.13% | – |
| PTN | Sell | Palatin Technologies Inc | $759,000 | -24.8% | 1,040,266 | -4.1% | 0.13% | +3.2% |
| ACRX | Sell | AcelRx Pharmaceuticals Inc | $673,000 | -57.7% | 100,000 | -65.5% | 0.12% | -41.6% |
| New | Ardelyx Inc | $618,000 | – | 32,700 | +100.0% | 0.10% | – | |
| KBIO | KaloBios Pharmaceuticals Inc | $605,000 | +11.6% | 349,560 | 0.0% | 0.10% | +53.7% | |
| MLNX | New | Mellanox Technologies Ltd | $535,000 | – | 12,517 | +100.0% | 0.09% | – |
| ICL | Sell | Israel Chemicals Ltd | $291,000 | -97.1% | 40,116 | -97.1% | 0.05% | -95.9% |
| ADHD | New | Alcobra Ltd | $144,000 | – | 38,500 | +100.0% | 0.02% | – |
| New | Energy Select Sector SPDR Fundput | $116,000 | – | 50,000 | +100.0% | 0.02% | – | |
| NVAX | New | Novavax Inc | $9,000 | – | 1,543 | +100.0% | 0.00% | – |
| GlaxoSmithKline PLCcall | $7,000 | -99.9% | 291,300 | 0.0% | 0.00% | -99.9% | ||
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -405 | -100.0% | -0.00% | – |
| AUXL | Exit | AUXILIUM PHARMACEUTICALS INC | $0 | – | -1,000 | -100.0% | -0.00% | – |
| MCUR | Exit | MACROCURE LTD | $0 | – | -7,100 | -100.0% | -0.01% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS I | $0 | – | -2,365 | -100.0% | -0.01% | – |
| SMMF | Exit | SUMMIT CORPORATION PLC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS | $0 | – | -63,331 | -100.0% | -0.03% | – |
| BLRX | Exit | BIOLINERX LTD-SPONS ADRsponsored adr | $0 | – | -193,284 | -100.0% | -0.04% | – |
| STEM | Exit | STEMCELLS INC | $0 | – | -485,500 | -100.0% | -0.08% | – |
| TLOG | Exit | TETRALOGIC PHARMACEUTICALS C | $0 | – | -194,200 | -100.0% | -0.10% | – |
| Exit | ALCOBRA LTDcall | $0 | – | -56,100 | -100.0% | -0.11% | – | |
| DSCO | Exit | DISCOVERY LABORATORIES INC | $0 | – | -485,500 | -100.0% | -0.11% | – |
| AFMD | Exit | AFFIMED NV | $0 | – | -150,000 | -100.0% | -0.12% | – |
| ORPN | Exit | BIO BLAST PHARMA LTD | $0 | – | -150,000 | -100.0% | -0.14% | – |
| EARS | Exit | AURIS MEDICAL AG | $0 | – | -191,300 | -100.0% | -0.14% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -50,000 | -100.0% | -0.17% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS INC | $0 | – | -97,100 | -100.0% | -0.23% | – |
| RNA | Exit | PROSENSA HOLDING BV | $0 | – | -219,345 | -100.0% | -0.23% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -53,405 | -100.0% | -0.24% | – |
| MA | Exit | MasterCard Inccl a | $0 | – | -26,000 | -100.0% | -0.24% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -291,300 | -100.0% | -0.24% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -534,050 | -100.0% | -0.24% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -89,817 | -100.0% | -0.25% | – |
| Exit | ARENA PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.26% | – | |
| GOOGL | Exit | Google Inccl a | $0 | – | -3,784 | -100.0% | -0.28% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -194,200 | -100.0% | -0.31% | – |
| CL | Exit | Colgate-Palmolive Co | $0 | – | -40,099 | -100.0% | -0.32% | – |
| GOOG | Exit | Google Inccl c | $0 | – | -4,540 | -100.0% | -0.32% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -111,085 | -100.0% | -0.33% | – |
| YUM | Exit | Yum! Brands Inc | $0 | – | -39,910 | -100.0% | -0.36% | – |
| SLB | Exit | Schlumberger Ltd | $0 | – | -28,790 | -100.0% | -0.36% | – |
| Exit | TJX Cos Inccall | $0 | – | -50,000 | -100.0% | -0.37% | – | |
| AVNR | Exit | AVANIR PHARMACEUTICALS INC-Acl a new | $0 | – | -250,000 | -100.0% | -0.37% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -61,173 | -100.0% | -0.37% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -100,000 | -100.0% | -0.37% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -150,000 | -100.0% | -0.39% | – |
| VFC | Exit | VF Corp | $0 | – | -47,900 | -100.0% | -0.39% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -155,360 | -100.0% | -0.71% | – |
| MDAS | Exit | MEDA AB-A SHS | $0 | – | -433,889 | -100.0% | -0.75% | – |
| Exit | ASTRAZENECA PLC-SPONS ADRcall | $0 | – | -97,100 | -100.0% | -0.86% | – | |
| Exit | SALIX PHARMACEUTICALS LTDcall | $0 | – | -48,500 | -100.0% | -0.94% | – | |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -207,406 | -100.0% | -2.73% | – |
| Exit | ALLERGAN INC | $0 | – | -128,840 | -100.0% | -2.84% | – | |
| ABBV | Exit | ABBVIE INC | $0 | – | -403,550 | -100.0% | -2.88% | – |
| MRK | Exit | MERCK & CO. INC. | $0 | – | -417,530 | -100.0% | -3.06% | – |
| Exit | Health Care Select Sector SPDRput | $0 | – | -485,500 | -100.0% | -3.83% | – | |
| Exit | SPDR S&P 500 ETF Trustput | $0 | – | -200,000 | -100.0% | -4.87% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.